Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Akaninyene A. Otu"'
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 7 (2022)
It is unclear how statin-use influences the adoption of healthy lifestyle choices. It is important to understand the nature of this relationship as this could facilitate targeted public health interventions which could help promote a healthy lifestyl
Externí odkaz:
https://doaj.org/article/59f990151a3c429bb23bd8dc0413c8e8
Autor:
Rita O. Oladele, Akaninyene A. Otu, Oluwaseyi J. Balogun, Oladayo M. Babalola, Augustina O. Nwosu, Iriagbonse Iyabo Osaigbovo, Titilayo Gbajabiamila, Nicholas K. Irurhe, Samuel A. Fayemiwo, Shuwaram A. Shettima, Nkolika Stella Uwaezuoke, Chinagozi Precious Edwin, Toyese Stephen Ayanbeku, Joy U. Okaa, Charles John Elikwu, David W. Denning, Phyllis J. Kanki, Folasade T. Ogunsola
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background and objectives: Commercial Aspergillus IgG antibody assays have become pivotal in the current diagnosis of chronic pulmonary aspergillosis (CPA). However, diagnostic cutoffs have been found to vary from manufactures’ recommendations in d
Externí odkaz:
https://doaj.org/article/486b8552a0944c63b161f53d030c2e6a
Autor:
Emmanuel E Effa, John Walley, Okey Okuzu, Stella Arakelyan, Akaninyene Asuquo Otu, Obiageli Onwusaka, Chiamaka Omoyele
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Objective To pilot the use of a scalable innovative mobile health (mHealth) non-communicable diseases (NCDs) training application for nurses at the primary care level.Design Mixed methods pilot of mHealth training on NCD care for nurses at primary he
Externí odkaz:
https://doaj.org/article/8703da46fe9b47819bae93f70c403a28
Autor:
Rita Oladele, Akaninyene Asuquo Otu, Olubunmi Olubamwo, Olufunmilola Bamidele Makanjuola, Ernest Afu Ochang, Joan Ejembi, Nicholas Irurhe, Iember Ajanaku, Halimat Ayodele Ekundayo, Adebola Olayinka, Oluwole Atoyebi, David Denning
Publikováno v:
The Pan African Medical Journal, Vol 36, Iss 297 (2020)
INTRODUCTION: It has been estimated that about 11.8% of the Nigerians suffer serious fungal infections annually. A high index of suspicion with early diagnosis and institution of appropriate therapy significantly impacts on the morbidity and mortalit
Externí odkaz:
https://doaj.org/article/655fba2f8308449294c007de313799b6
Publikováno v:
Briefings in Functional Genomics. 22:241-249
The COVID-19 pandemic has ushered in high-throughput sequencing technology as an essential public health tool. Scaling up and operationalizing genomics in Africa is crucial as enhanced capacity for genome sequencing could address key health problems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d45f42a90cd6f3ce12b1f1ffccb63523
https://doi.org/10.1093/bfgp/elac040
https://doi.org/10.1093/bfgp/elac040
Autor:
Uchenna C Okonkwo, Henry C Okpara, Kenneth Inaku, Tony M Aluka, Evaristus S Chukwudike, Yeonun Ogarekpe, Emin J Emin, Osim Hodo, Akaninyene A Otu
Publikováno v:
African health sciences. 22(1)
Background: Hepatitis D virus (HDV) can cause a chronic infection in the presence of hepatitis B surface antigen and contribute to the burden of chronic liver disease especially in regions where chronic hepatitis B virus (HBV) infection is endemic. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a028a74c89ff18e245eb4e575fc28a
https://pubmed.ncbi.nlm.nih.gov/36032492
https://pubmed.ncbi.nlm.nih.gov/36032492
Autor:
Chibuike Ibe, Akaninyene Asuquo Otu
Publikováno v:
FEMS yeast research. 22(1)
Invasive fungal infections are a serious concern globally, especially in African settings which are typified by poorly funded and fragile healthcare systems. Low performance diagnostics, limited therapeutics and poor societal awareness of invasive fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d75c131c7ed252e4d217ec5cdff834
https://pubmed.ncbi.nlm.nih.gov/36259762
https://pubmed.ncbi.nlm.nih.gov/36259762
Autor:
Felix Bongomin, Akaninyene A Otu
Publikováno v:
Therapeutic Advances in Infectious Disease
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background and Aims: Patients with chronic pulmonary aspergillosis (CPA) who discontinue antifungal therapy commonly exhibit disease recurrence. We aimed to evaluate the utility of the St. George’s respiratory questionnaire (SGRQ) in predicting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94dd2f454d277768ec07f36f73e5026
http://europepmc.org/articles/PMC8323403
http://europepmc.org/articles/PMC8323403
Publikováno v:
Otu, A A, Langridge, P & Denning, D W 2019, ' An evaluation of nebulised amphotericin B deoxycholate (Fungizone® ) for treatment of pulmonary aspergillosis in the UK National Aspergillosis Centre ', MYCOSES, vol. 62, no. 11, pp. 1049-1055 . https://doi.org/10.1111/myc.12996
Antifungal treatment options for allergic bronchopulmonary aspergillosis (ABPA) and severe asthma with fungal sensitisation (SAFS) are largely limited to itraconazole based on the outcome of randomised controlled trials. It is unclear if nebulised am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0969e3fa5bafc6903873f5137e4dcdc0
https://doi.org/10.1111/myc.12996
https://doi.org/10.1111/myc.12996